Table 3.

Expanded Phase II: Responses to treatment for the mITT population (n = 79).

Best Response	Disease Control Rate	Median OS Months (Range) [CI]	Median PFS Months (Range) [CI]	6-Month OS Rate	6-Month PFS Rate
6 CR, 14 PR, 49 SD, 10 PD (25.3% ORR)	87.3%	24.6 (1.6–46.5) (CI 95%: 17.0–.)	6.7 (0.9–44.0) (CI 95%: 4.4–7.9)	89.9%	53.2%

Note: Two patients with PR and one patient with SD had surgical CRs.